Double Medical Technology Inc.

SZSE:002901 Stock Report

Market Cap: CN¥13.1b

Double Medical Technology Future Growth

Future criteria checks 5/6

Double Medical Technology is forecast to grow earnings and revenue by 44.8% and 21.6% per annum respectively. EPS is expected to grow by 44.9% per annum. Return on equity is forecast to be 14.8% in 3 years.

Key information

44.8%

Earnings growth rate

44.9%

EPS growth rate

Medical Equipment earnings growth26.5%
Revenue growth rate21.6%
Future return on equity14.8%
Analyst coverage

Low

Last updated22 May 2024

Recent future growth updates

Recent updates

Market Participants Recognise Double Medical Technology Inc.'s (SZSE:002901) Revenues Pushing Shares 29% Higher

Oct 01
Market Participants Recognise Double Medical Technology Inc.'s (SZSE:002901) Revenues Pushing Shares 29% Higher

Is Double Medical Technology (SZSE:002901) A Risky Investment?

Sep 27
Is Double Medical Technology (SZSE:002901) A Risky Investment?

Capital Allocation Trends At Double Medical Technology (SZSE:002901) Aren't Ideal

Sep 05
Capital Allocation Trends At Double Medical Technology (SZSE:002901) Aren't Ideal

Double Medical Technology (SZSE:002901) Seems To Use Debt Quite Sensibly

Jun 19
Double Medical Technology (SZSE:002901) Seems To Use Debt Quite Sensibly

Investors Could Be Concerned With Double Medical Technology's (SZSE:002901) Returns On Capital

May 28
Investors Could Be Concerned With Double Medical Technology's (SZSE:002901) Returns On Capital

Earnings and Revenue Growth Forecasts

SZSE:002901 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,080625N/A8432
12/31/20252,579466N/A5382
12/31/20242,017305N/A2862
9/30/20241,937201-26272N/A
6/30/20241,748104-20265N/A
3/31/20241,56962-97228N/A
12/31/20231,53359-23274N/A
9/30/20231,325-22-198101N/A
6/30/20231,3566-24062N/A
3/31/20231,39439-146138N/A
12/31/20221,43493-157128N/A
9/30/20221,924432111379N/A
6/30/20221,976536184454N/A
3/31/20222,050654248510N/A
1/1/20221,994673438673N/A
9/30/20211,782632402608N/A
6/30/20211,761658446625N/A
3/31/20211,732647465617N/A
12/31/20201,587606419556N/A
9/30/20201,497550246508N/A
6/30/20201,387522226502N/A
3/31/20201,27047283393N/A
12/31/20191,257465115434N/A
9/30/20191,097431150346N/A
6/30/2019964404139323N/A
3/31/2019835386206342N/A
12/31/2018772371231335N/A
9/30/2018698368261341N/A
6/30/2018670339N/A309N/A
3/31/2018620308N/A296N/A
12/31/2017594296N/A314N/A
9/30/2017560261N/A268N/A
12/31/2016463219N/A207N/A
12/31/2015392189N/A123N/A
12/31/2014299139N/A151N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002901's forecast earnings growth (44.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 002901's earnings (44.8% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 002901's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 002901's revenue (21.6% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 002901's revenue (21.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 002901's Return on Equity is forecast to be low in 3 years time (14.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y